Trial Profile
Phase I study to evaluate the effect of ketoconazole on the pharmacokinetics of dasatinib and the effect of dasatinib on pharmacodynamic markers in patients with advanced solid tumors
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 27 Apr 2011
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary) ; Ketoconazole
- Indications Solid tumours
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 02 Jan 2006 New trial record.